Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, a study by the London School of Hygiene and Tropical Medicine (LSHTM) has concluded.
The UK has had more than 71,000 deaths from the coronavirus and has recorded over 2.3 million cases of COVID-19 infections as of late Monday, according to a Reuters tally.
“The most stringent intervention scenario with tier 4 England-wide and schools closed during January and 2 million individuals vaccinated per week, is the only scenario we considered which reduces peak ICU burden below the levels seen during the first wave,” the study said.
“In the absence of substantial vaccine roll-out, cases, hospitalisations, ICU admissions and deaths in 2021 may exceed those in 2020.”
An accelerated uptake of two million vaccinated per week “is predicted to have a much more substantial impact,” it added. The study has yet to be peer-reviewed.
Prime Minister Boris Johnson and his scientific advisers have said a variant of the coronavirus, which could be up to 70% more transmissible, was spreading rapidly in Britain, although it is not thought to be more deadly or to cause more serious illness.
- PHAC finds no evidence of mystery brain disease in New Brunswick, says patients still need answers
- Beer recall hits 2 more Canadian products, bringing total to 31
- Alberta expanding use of AI tech that speeds up MRIs after successful pilot
- Stopping GLP-1 drugs could increase heart attack risk for some, study says
Get weekly health news
That prompted tight social mixing restrictions measures for London and southeast England, while plans to ease curbs over Christmas across the nation were dramatically scaled back or scrapped altogether.
Media reports over the weekend said that the United Kingdom will roll out the Oxford-AstraZeneca COVID-19 vaccine from Jan. 4, with its approval by the country’s medical regulator expected within days.
Earlier this month, the United Kingdom became the first country in the world to roll out the vaccine made by Pfizer and BioNTech.
The British government said on Thursday that 600,000 people in the United Kingdom have received the first dose of the Pfizer-BioNTech COVID-19 vaccine since inoculations began.
(Reporting by Kanishka Singh in Bengaluru; Editing by Michael Perry)
Comments
Want to discuss? Please read our Commenting Policy first.